LimmaTech Biologics AG

Swiss Biotech Association

Member

LimmaTech Biologics AG is a clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antimicrobial resistance and sexually transmitted diseases. Additionally, we develop vaccines together with GSK.

http://www.lmtbio.com
+41 44 733 85 85
info@lmtbio.com
Patricia Martin

Location

Grabenstrasse 3, 8952 Schlieren, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2015
Number of employees in Switzerland

20-49

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Altorfer Engineering GmbH

Altorfer Engineering is a contractor and consulting company with expertise in providing engineering and project management services, due diligence assessments as well as technology transfer for aseptic drug product and biologics processes.
6300 Zug

Member

ATLyphe AG

ATLyphe is a Swiss biotech startup with the goal of developing antibody-based solutions engaging T cells for precision immunotherapy. We aim to not only provide less toxic and more precise treatments for current patients but also increase the total number of patients eligible to receive the therapy.
8006 Zürich

Member

Blueprint Medicines (Switzerland GmbH)

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.
6300 Zug

Member